Dr. Michael Ruoff - Net Worth and Insider Trading

Dr. Michael Ruoff Net Worth

The estimated net worth of Dr. Michael Ruoff is at least $0 dollars as of 2024-06-25. Dr. Michael Ruoff is the Supervisory Board of Cantourage Group SE and owns about 0 shares of Cantourage Group SE (FRA:HIGH) stock worth over $0. Dr. Michael Ruoff is also the Supervisory Board of Cantourage Group SE and owns about 0 shares of Cantourage Group SE (XTER:HIGH) stock worth over $0. Details can be seen in Dr. Michael Ruoff's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Dr. Michael Ruoff has not made any transactions after 2022-11-14 and currently still holds the listed stock(s).

Transaction Summary of Dr. Michael Ruoff

Dr. Michael Ruoff Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Dr. Michael Ruoff owns 2 companies in total, including Cantourage Group SE (XTER:HIGH) , and Cantourage Group SE (FRA:HIGH) .

Click here to see the complete history of Dr. Michael Ruoff’s form 4 insider trades.

Insider Ownership Summary of Dr. Michael Ruoff

Ticker	Comapny	Transaction Date	Type of Owner
XTER:HIGH	Cantourage Group SE	2022-11-14	Supervisory Board
FRA:HIGH	Cantourage Group SE	2022-11-14	Supervisory Board

Dr. Michael Ruoff Latest Holdings Summary

Dr. Michael Ruoff currently owns a total of 2 stocks. Among these stocks, Dr. Michael Ruoff owns 0 shares of Cantourage Group SE (FRA:HIGH) as of November 14, 2022, with a value of $0 . Dr. Michael Ruoff also owns 0 shares of Cantourage Group SE (XTER:HIGH) as of November 14, 2022, with a value of $0 .

Latest Holdings of Dr. Michael Ruoff

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
FRA:HIGH	Cantourage Group SE	2022-11-14	0	6.90	0
XTER:HIGH	Cantourage Group SE	2022-11-14	0	6.95	0

Holding Weightings of Dr. Michael Ruoff

Dr. Michael Ruoff Form 4 Trading Tracker

According to the SEC Form 4 filings, Dr. Michael Ruoff has made a total of 5 transactions in Cantourage Group SE (FRA:HIGH) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Cantourage Group SE is the sale of 1,000 shares on November 14, 2022, which brought Dr. Michael Ruoff around $33,250.

According to the SEC Form 4 filings, Dr. Michael Ruoff has made a total of 4 transactions in Cantourage Group SE (XTER:HIGH) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Cantourage Group SE is the sale of 244 shares on November 14, 2022, which brought Dr. Michael Ruoff around $6,100.

Insider Trading History of Dr. Michael Ruoff

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Dr. Michael Ruoff Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Dr. Michael Ruoff Ownership Network

Ownership Network List of Dr. Michael Ruoff

No Data

Ownership Network Relation of Dr. Michael Ruoff

Dr. Michael Ruoff Owned Company Details

What does Cantourage Group SE do?

Who are the key executives at Cantourage Group SE?

Dr. Michael Ruoff is the Supervisory Board of Cantourage Group SE. Other key executives at Cantourage Group SE include Supervisory Board Patrick Hoffmann , Supervisory Board Dr. Florian Kainzinger , and Supervisory Board Dr. / Dr. Florian / Michael Kainzinger / Ruoff .

Cantourage Group SE (XTER:HIGH) Insider Trades Summary

Over the past 18 months, Dr. Michael Ruoff made no insider transaction in Cantourage Group SE (XTER:HIGH). Other recent insider transactions involving Cantourage Group SE (XTER:HIGH) include a net purchase of 150 shares made by Patrick Hoffmann ,

In summary, during the past 3 months, insiders sold 0 shares of Cantourage Group SE (XTER:HIGH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cantourage Group SE (XTER:HIGH) were sold and 150 shares were bought by its insiders, resulting in a net purchase of 150 shares.

Cantourage Group SE (XTER:HIGH)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cantourage Group SE Insider Transactions

No Available Data

Dr. Michael Ruoff Mailing Address

Above is the net worth, insider trading, and ownership report for Dr. Michael Ruoff. Currently GuruFocus does not have mailing address information for Dr. Michael Ruoff.

Discussions on Dr. Michael Ruoff

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.